Cannabigerol (CBG) is a non-intoxicating cannabinoid found in cannabis. CBG has many potential therapeutic benefits, including antibacterial, antimicrobial, and anti-inflammatory qualities.
CBG interacts with the body’s endocannabinoid system by interacting with both CB1 and CB2 receptors and stimulating a response. These receptors regulate physiological processes such as mood, pain response, and appetite. Recent preclinical research has indicated that CBG has a stronger affinity for the CB2 receptor. CBG seems to interact with the endocannabinoid system in a number of possibly therapeutic ways.
CBG shares some similarities with CBD: it seems to be anti-inflammatory and anti-bacterial. However, CBG also boasts its own unique set of properties, offering potential therapeutic benefits such as treatment for inflammatory bowel disease and glaucoma in animal tests.